সুইজারল্যান্ড -
ইতালীয় -
Swissmedic (Swiss Agency for Therapeutic Products)
fasenra pen 30 mg /1 ml lnjektionslösung
astrazeneca ag - benralizumabum - lnjektionslösung - benralizumabum 30 mg, histidinum, histidini hydrochloridum monohydricum, trehalosum dihydricum, polysorbatum 20, aqua ad iniectabile q.s. ad solutionem pro 1 ml. - schweres eosinophiles asma - biotechnologika
সুইজারল্যান্ড -
ইতালীয় -
Swissmedic (Swiss Agency for Therapeutic Products)
bydureon bcise 2 mg depot-lnjektionssuspension in einem autoinjektor
astrazeneca ag - exenatidum - depot-lnjektionssuspension in einem autoinjektor - exenatidum 2 mg, saccharum, poly(lactidum-co-glycolidum) 50/50 (0.40 - 0.49 dl/g), triglycerida media, ad suspensionem pro dosi. - antidiabetico - synthetika
সুইজারল্যান্ড -
ইতালীয় -
Swissmedic (Swiss Agency for Therapeutic Products)
calquence 100 mg capsule rigide
astrazeneca ag - acalabrutinibum - capsule rigide - acalabrutinibum 100 mg, cellulosum microcristallinum silicificatum, amylum pregelificatum, carboxymethylamylum natricum a corresp. natrium max. 0.25 mg, magnesii stearas, kapselhülle: gelatina, e 172 (flavum), e 132, e 171, drucktinte: lacca, e 172 (nigrum), propylenglycolum, ammonii hydroxidum, pro capsula. - chronisch lymphatische leukämie (cll) - synthetika
সুইজারল্যান্ড -
ইতালীয় -
Swissmedic (Swiss Agency for Therapeutic Products)
trixeo aerosphere 5/7.2/160 μg druckgasinhalation, suspension
astrazeneca ag - budesonidum, glycopyrronium, formoteroli fumaras dihydricus - druckgasinhalation, suspension - budesonidum 160 µg, glycopyrronii bromidum 9 µg corresp. glycopyrronium 7.2 µg, formoteroli fumaras dihydricus 5 µg, 1,2-distearoyl-sn-glycero-3-phosphocholinum, calcii chloridum dihydricum, norfluranum, ad suspensionem pro dosi. - bpco - synthetika
সুইজারল্যান্ড -
ইতালীয় -
Swissmedic (Swiss Agency for Therapeutic Products)
tezspire soluzione iniettabile in siringa preriempita
astrazeneca ag - tezepelumabum - soluzione iniettabile in siringa preriempita - tezepelumabum 210 mg, prolinum, acidum aceticum glaciale, polysorbatum 80, natrii hydroxidum q.s. ad ph, aqua ad iniectabile, ad solutionem pro 1.91 ml. - zusatztherapie bei schwerem asthma - biotechnologika
সুইজারল্যান্ড -
ইতালীয় -
Swissmedic (Swiss Agency for Therapeutic Products)
bydureon pen polvere e solvente per la produzione di un deposito-sospensione iniettabile
astrazeneca ag - exenatidum - polvere e solvente per la produzione di un deposito-sospensione iniettabile - exenatidum 2 mg, poli(lactidum-co-glycolidum) 50/50, zucchero, carmellosum natricum, natrii chloridum, polysorbatum 20, natrii dihydrogenophosphas monohydricus, dinatrii phosphas heptahydricus, natrii hydroxidum del ph, acqua per iniectabilia q.s. la sospensione, per dosi corrisp. sodio 4.39 mg. - antidiabetico - synthetika
সুইজারল্যান্ড -
ইতালীয় -
Swissmedic (Swiss Agency for Therapeutic Products)
pulmicort turbuhaler 200 polvere per inalazione
astrazeneca ag - budesonidum - polvere per inalazione - budesonidum 200 µg pro dosi, doses pro vase 200. - ostruttiva malattie respiratorie - synthetika
সুইজারল্যান্ড -
ইতালীয় -
Swissmedic (Swiss Agency for Therapeutic Products)
pulmicort turbuhaler 100 polvere per inalazione
astrazeneca ag - budesonidum - polvere per inalazione - budesonidum 100 µg pro dosi, dosi pro vaso 200. - ostruttiva malattie respiratorie - synthetika
সুইজারল্যান্ড -
ইতালীয় -
Swissmedic (Swiss Agency for Therapeutic Products)
pulmicort turbuhaler 400 polvere per inalazione
astrazeneca ag - budesonidum - polvere per inalazione - budesonidum 400 µg pro dosi, doses pro vase 50. - ostruttiva malattie respiratorie - synthetika
সুইজারল্যান্ড -
ইতালীয় -
Swissmedic (Swiss Agency for Therapeutic Products)
pulmicort respules 0,25 mg/ml sospensione
astrazeneca ag - budesonidum - sospensione - budesonidum 0.25 mg, dinatrii edetas, natrii chloridum, polysorbatum 80, acidum citricum, natrii citras dihydricus, aqua ad iniectabile q.s. ad suspensionem pro 1 ml. - ostruttiva malattie respiratorie - synthetika